The devices have been proven to lift people’s moods, boost alertness and help those who use them feel more energised ...
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
The U.S. Food and Drug Administration on Tuesday approved the first nasal spray that will help with treating major depressive ...
President Donald Trump has signed an executive order promising to eliminate what he incorrectly labels “the electric vehicle ...
Asia Raines with Harlee and Harper Women's Association talks about the group's workshop for helping women manage depression ...
Spravato is a first-of-its-kind medication to help manage treatment-resistant depression, according to the pharmaceutical company. The nasal spray can be given to people who haven’t seen improvements ...
It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...
When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...
Already on its way to becoming a blockbuster drug, Johnson & Johnson’s Spravato has received another potential boost as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback